Lower levels of "bad" LDL cholesterol could mean a lower risk of dementia and Alzheimer's disease, a new study says.

Biogen (NASDAQ:BIIB) said on Wednesday that the U.S. FDA has granted Fast Track designation to BIIB080, its antisense ...

A new blood test test could determine how far Alzheimer's has progressed and could also help confirm whether another ...

W ith two new treatments for Alzheimer’s disease approved in recent years, there’s growing hope for people at risk of the ...

Albers and colleagues are interested in whether olfactory dysfunction — the sometimes-subtle loss of sense of smell — can ...

Eli Lilly & Co. is adding Alzheimer’s disease resources to the online platform it launched a year ago to sell obesity, ...

Most people donning virtual reality (VR) goggles are seeking the thrill of being immersed in a fictitious video game world.

With new dementia cases expected to double in the United States by 2060, the therapy could be a difference maker. But ...

Early-onset Alzheimer’s disease progresses more rapidly and often strikes people in the prime of their lives. A new treatment ...

The findings suggest that the shingles virus might play a role in causing at least a subset of dementia cases, Geldsetzer says, and the vaccine may protect against that. Alternatively, it could be ...

Now, a study has found that low levels of LDL-C, or ‘bad’ cholesterol, may reduce the risk of developing dementia. Statins, a ...

LDL levels below 70 mg/dL are tied to a lower risk of developing dementia in general and Alzheimer’s disease-related dementia ...